zalcitabine has been researched along with ARC in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (27.59) | 18.7374 |
| 1990's | 21 (72.41) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cameron, J; Cammack, N; Cooley, TP; Gu, Z; Hirst, HM; McCaffrey, R; Montaner, JS; Ruedy, J; Salomon, H; Wainberg, MA | 1 |
| Lissen, E | 1 |
| Khoo, SH; Wilkins, EG | 1 |
| Dormont, J | 1 |
| Antoniskis, D; Arezzo, J; Bigley, J; Bozzette, SA; Fischl, MA; Gelb, LD; Gocke, DJ; Grieco, MH; Hirsch, MS; Hyslop, NE; Leedom, JM; Lim, L; LoFaro, ML; McKinley, GF; Merigan, TC; Murphy, RL; Pettinelli, CB; Pottage, JC; Powderly, WG; Ray, G; Reed, N; Richman, DD; Schaumburg, HH; Simon, G; Skowron, G; Soo, W; Spector, SA; Sperber, SJ; Uttamchandani, RB; Zachary, J | 1 |
| Arduino, JM; Chung, R; Crumpacker, CS; Hammer, SM; Japour, AJ; Lane, J; Mayers, DL; McLeod, GX; Reichman, R; Wagner, KF | 1 |
| Broder, S; Gao, WY; Johns, DG; Mitsuya, H; Shirasaka, T | 1 |
| French, MA; Martinez, OP | 1 |
| Brawley, O; Broder, S; Cohen, RB; Nguyen, BY; Pluda, JM; Shay, LE; Venzon, DJ; Whitcup, SM; Wyvill, KM; Yarchoan, R | 1 |
| Holazo, AA; Limjuco, R; Massarella, JW; Min, B; Nazareno, LA; Passe, S; Twardy, SK | 1 |
| Boucher, CA; Cammack, N; Hill, A; Ingrand, D; Loveday, C; Robert, C; Weber, J | 1 |
| Gries, JM; Jacobson, M; Sheiner, LB; Troconiz, IF; Verotta, D | 1 |
| Töglhofer, W | 1 |
| Mahler, W | 1 |
| Clifford, DB; Klebert, MK; Powderly, WG | 1 |
| Dunton, AW; Fukuda, EK; Gustavson, LE; Rubio, FA | 1 |
| Merigan, TC; Skowron, G | 2 |
| Fischl, MA; Meng, TC; Richman, DD | 1 |
| Darby, G; Larder, BA; Richman, DD | 1 |
| Bozzette, SA; Fischl, M; Hirsch, M; Merigan, TC; Pettinelli, C; Richman, D; Schooley, R; Skowron, G; Soo, W; Uttamchandani, R | 1 |
| Ganser, A; Greher, J; Hoelzer, D; Staszewski, S; Völkers, B | 1 |
| Broder, S; Dalakas, M; Dubinsky, RM; Yarchoan, R | 1 |
| Allain, JP; Dubinsky, R; Fischl, MA; Klecker, RW; McAtee, N; McNeely, MC; Perno, CF; Thomas, RV; Wills, RJ; Yarchoan, R | 1 |
| Offerhaus, L | 1 |
6 review(s) available for zalcitabine and ARC
| Article | Year |
|---|---|
[Anti-HIV therapy (1987-1994): from nothing to confusion].
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Clinical Trials as Topic; Didanosine; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Time Factors; Zalcitabine; Zidovudine | 1995 |
Controversies in anti-retroviral therapy of adults.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; AIDS-Related Complex; AIDS-Related Opportunistic Infections; CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; Drug Tolerance; HIV Infections; HIV-1; Humans; Zalcitabine; Zidovudine | 1995 |
Future treatment strategies in HIV infection.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Antiviral Agents; Biomarkers; CD4 Lymphocyte Count; Didanosine; Forecasting; HIV Infections; Humans; Zalcitabine; Zidovudine | 1994 |
Safety and tolerance of dideoxycytidine as a single agent. Results of early-phase studies in patients with acquired immunodeficiency syndrome (AIDS) or advanced AIDS-related complex. Study Group of the AIDS Clinical Trials Group of the National Institute
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Drug Evaluation; Drug Tolerance; Gene Products, gag; HIV Antigens; HIV Core Protein p24; HIV-1; Humans; Viral Core Proteins; Zalcitabine | 1990 |
Alternating and intermittent regimens of zidovudine (3'-azido-3'-deoxythymidine) and dideoxycytidine (2',3'-dideoxycytidine) in the treatment of patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Clinical Protocols; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Tolerance; Humans; Zalcitabine; Zidovudine | 1990 |
AIDS Clinical Trials Group: phase I/II study of combination 2',3'-dideoxycytidine and zidovudine in patients with acquired immunodeficiency syndrome (AIDS) and advanced AIDS-related complex.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Clinical Protocols; Drug Evaluation; Drug Therapy, Combination; Humans; Zalcitabine; Zidovudine | 1990 |
11 trial(s) available for zalcitabine and ARC
| Article | Year |
|---|---|
Development of HIV-1 resistance to (-)2'-deoxy-3'-thiacytidine in patients with AIDS or advanced AIDS-related complex.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; AIDS-Related Complex; Base Sequence; DNA Primers; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Female; HIV Reverse Transcriptase; HIV-1; Humans; In Vitro Techniques; Lamivudine; Male; Molecular Sequence Data; Mutation; Phenotype; Proviruses; Reverse Transcriptase Inhibitors; RNA, Viral; Time Factors; Zalcitabine | 1995 |
Alternating and intermittent regimens of zidovudine and dideoxycytidine in patients with AIDS or AIDS-related complex.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; CD4-Positive T-Lymphocytes; Drug Administration Schedule; Drug Therapy, Combination; Female; Hematologic Diseases; HIV Core Protein p24; Humans; Leukocyte Count; Male; Peripheral Nervous System Diseases; Weight Gain; Zalcitabine; Zidovudine | 1993 |
The effect of food on pharmacokinetics of zalcitabine in HIV-positive patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; Antiviral Agents; Biological Availability; Female; Food; HIV Infections; Humans; Male; Middle Aged; Reverse Transcriptase Inhibitors; Zalcitabine | 1995 |
Phase I/II study of 3TC (lamivudine) in HIV-positive, asymptomatic or mild AIDS-related complex patients: sustained reduction in viral markers. The Lamivudine European HIV Working Group.
Topics: Adult; AIDS-Related Complex; Antigen-Antibody Complex; Antiviral Agents; Dose-Response Relationship, Drug; HIV; HIV Core Protein p24; HIV Infections; HIV Seropositivity; Humans; Lamivudine; Leukocytes, Mononuclear; Male; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; Viremia; Zalcitabine | 1995 |
A pooled analysis of CD4 response to zidovudine and zalcitabine treatment in patients with AIDS and AIDS-related complex.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Anti-HIV Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; Humans; Regression Analysis; Time Factors; Zalcitabine; Zidovudine | 1997 |
A pilot study of the bioavailability and pharmacokinetics of 2',3'-dideoxycytidine in patients with AIDS or AIDS-related complex.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; AIDS-Related Complex; Biological Availability; Gas Chromatography-Mass Spectrometry; Humans; Male; Middle Aged; Pilot Projects; Zalcitabine | 1990 |
Alternating and intermittent regimens of zidovudine (3'-azido-3'-deoxythymidine) and dideoxycytidine (2',3'-dideoxycytidine) in the treatment of patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Clinical Protocols; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Tolerance; Humans; Zalcitabine; Zidovudine | 1990 |
Circulating p24 antigen levels and responses to dideoxycytidine in human immunodeficiency virus (HIV) infections. A phase I and II study.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; AIDS-Related Complex; Dideoxynucleosides; Drug Evaluation; Female; HIV Antigens; HIV Core Protein p24; Humans; Male; Random Allocation; Retroviridae Proteins; Zalcitabine | 1989 |
FDA expands testing of anti-AIDS drugs.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS Dementia Complex; AIDS-Related Complex; Antiviral Agents; Clinical Trials as Topic; Didanosine; Humans; Infant; Infant, Newborn; United States; United States Food and Drug Administration; Zalcitabine; Zidovudine | 1989 |
New treatment being tested against AIDS and ARC.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Clinical Trials as Topic; HIV; Humans; Virus Replication; Zalcitabine | 1987 |
[Azidothymidine and HIV infection].
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Antiviral Agents; Clinical Trials as Topic; Deoxycytidine; Drug Interactions; Humans; Thymidine; Zalcitabine; Zidovudine | 1987 |
13 other study(ies) available for zalcitabine and ARC
| Article | Year |
|---|---|
Dideoxynucleoside resistance emerges with prolonged zidovudine monotherapy. The RV43 Study Group.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Didanosine; Drug Resistance, Microbial; HIV Seropositivity; HIV-1; Humans; Leukocytes, Mononuclear; Microbial Sensitivity Tests; Time Factors; Zalcitabine; Zidovudine | 1994 |
Differential phosphorylation of azidothymidine, dideoxycytidine, and dideoxyinosine in resting and activated peripheral blood mononuclear cells.
Topics: 5'-Nucleotidase; Acquired Immunodeficiency Syndrome; Adenosine Kinase; AIDS-Related Complex; Chromatography, High Pressure Liquid; Deoxycytidine Kinase; Deoxyribonucleotides; Didanosine; HIV-1; Humans; Kinetics; Microbial Sensitivity Tests; Monocytes; Phosphorylation; Thymidine Kinase; Uridine Kinase; Zalcitabine; Zidovudine | 1993 |
Acoustic neuropathy associated with zalcitabine-induced peripheral neuropathy.
Topics: AIDS-Related Complex; Hearing Loss, Sensorineural; Humans; Hypesthesia; Male; Middle Aged; Peripheral Nervous System Diseases; Tinnitus; Vestibulocochlear Nerve Diseases; Zalcitabine | 1993 |
A pilot study of sequential therapy with zidovudine plus acyclovir, dideoxyinosine, and dideoxycytidine in patients with severe human immunodeficiency virus infection.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; AIDS-Related Complex; Antigens, CD; Biomarkers; Body Weight; CD4 Antigens; Didanosine; Drug Administration Schedule; Drug Therapy, Combination; HIV Core Protein p24; Humans; Male; Middle Aged; Pilot Projects; T-Lymphocyte Subsets; Time Factors; Zalcitabine; Zidovudine | 1993 |
[New, in Austria registered specialty drugs. Hivid (2',3'-dideoxycytidine; ddC)].
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Animals; Antiviral Agents; Austria; CD4-Positive T-Lymphocytes; Humans; Leukocyte Count; Zalcitabine; Zidovudine | 1992 |
Treatment IND for dideoxycytidine.
Topics: AIDS-Related Complex; Clinical Protocols; Humans; United States; United States Food and Drug Administration; Zalcitabine | 1991 |
[AIDS: initial results of combination therapy. AIDS and ARC--alternating or intermittent medication].
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; CD4 Antigens; Combined Modality Therapy; HIV; Humans; Immunotherapy, Adoptive; Interferon Type I; Recombinant Proteins; Zalcitabine; Zidovudine | 1991 |
Expanded access for AIDS drug.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Humans; Zalcitabine | 1991 |
Ototoxicity associated with dideoxycytidine.
Topics: Adult; AIDS-Related Complex; Drug Administration Schedule; Hearing Loss, Sensorineural; Hearing Tests; Humans; Male; Zalcitabine | 1990 |
HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Dideoxynucleosides; Drug Resistance; Foscarnet; HeLa Cells; HIV; HIV Core Protein p24; Humans; Microbial Sensitivity Tests; Phosphonoacetic Acid; Retroviridae Proteins; Reverse Transcriptase Inhibitors; Viral Plaque Assay; Virus Replication; Zalcitabine; Zidovudine | 1989 |
Inhibitory effect of azidothymidine, 2'-3'-dideoxyadenosine, and 2'-3'-dideoxycytidine on in vitro growth of hematopoietic progenitor cells from normal persons and from patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Bone Marrow; Colony-Forming Units Assay; Deoxyribonucleosides; Dideoxyadenosine; Dideoxynucleosides; Dose-Response Relationship, Drug; Growth Inhibitors; Hematopoiesis; Hematopoietic Stem Cells; Humans; Zalcitabine; Zidovudine | 1989 |
Reversible axonal neuropathy from the treatment of AIDS and related disorders with 2',3'-dideoxycytidine (ddC).
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; Axons; Dose-Response Relationship, Drug; Electromyography; Humans; Pain; Peripheral Nervous System Diseases; Zalcitabine | 1989 |
Phase I studies of 2',3'-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT).
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; Deoxycytidine; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; HIV; Humans; Male; Middle Aged; Thymidine; Zalcitabine; Zidovudine | 1988 |